Tag Archive for: Webinar

In order to maximize your funding potential, all sources of funding must be considered, including the less traditional ones.

The NIH’s R21 mechanism aims to fund very early stage proof of concept type programs of up to 2 years at about $300,000, whereas the R01 mechanism is more suitable for longer programs of up to 5 years, totaling close to $3,000,000. Other agencies such as the Department of Defense, BARDA, FDA, and NSF also have awards for research in the life sciences.

In this webinar, we share insight into alternatives to the classic SBIR/STTR mechanisms. We will discuss methodology for establishing both responsiveness as well as competitiveness and how to increase chances for award.

View Slide Deck

SBIR/STTR awards account for over $780,000,000 awarded per year by NIH alone. These are excellent sources of funding aimed at promoting R&D activities of US-based small businesses as well as collaborations with Academics.

SBIR/STTRs differ from traditional NIH mechanisms in that they are highly product driven and ultimately are seeking commercialization of novel therapies, diagnostics, devices, etc.

In this webinar, we discuss process for applying, guidelines, key success components and insight into increasing chances for award.

View Slide Deck

Every year, US-based non-dilutive sources of funding award billions of dollars towards clinical stage research in the Life Sciences.

Funding is available for clinical stage funding across scientific fields including Infectious Diseases, Neurosciences, Cardiovascular, and many more. These funds come from multiple Institutes within the NIH, such as NIAID, NIAMS, NIDDK, from BARDA, and from the DOD.

In this webinar, we discuss the process for applying, guidelines, key success components and insight into increasing chances for award.

 

View Slide Deck

Every year, US-based non-dilutive sources of funding award billions of dollars towards pre-clinical stage research in the Life Sciences.

Funding is available for pre-clinical research across scientific fields including Infectious Diseases, Oncology, Neurosciences, and many more. These funds come from Institutes within the NIH, such as NIAID, NCI, NINDS, the NSF, the DoD, and private foundations. The NIH alone annually funds over $15B to pre-clinical stage R&D in the life sciences.

In this webinar we discuss the process for applying, guidelines, key success components, and insight into increasing chances for award.

View Slide Deck

NIH alone awards roughly $6B annually to Cancer related R&D grants and contracts. The scope of funding support covers much of the R&D cycle with an emphasis on pre-clinical work, and may cover clinical stage activities as well.

In this webinar, we discuss key cancer related opportunities, mainly within the National Cancer Institute (NCI), that are available for life science organizations.

View Slide Deck

The National Institute of Allergies and Infectious Diseases (NIAID) awards close to $6,000,000,000 annually. Taking into account activities by DTRA, DARPA, US Army, BARDA, etc., this is a funding force no one in the field can afford to ignore.

In this webinar, we introduce you to Biodefense and Infectious Diseases sources of funding such as NIAID, DTRA, DARPA, US Army, and BARDA, and give examples of current open solicitations. We discuss the process for applying, major challenges, and how to maximize your chances for award.

 

View Slide Deck

Opening FreeMind’s 2017 webinar series is an introduction to the SBIR and STTR mechanisms which account for over $780,000,000 awarded per year by NIH alone. These are excellent sources of funding aimed at promoting R&D activities of US-based small businesses as well as collaborations with Academics.

SBIR/STTRs differ from traditional NIH mechanisms in that they are highly product driven and ultimately are seeking commercialization of novel therapies, diagnostics, devices, etc.

In this webinar we discussed process for applying, guidelines, key success components and insight into increasing chances for award.

 

View slide deck

SBIR/STTR awards account for over $780,000,000 awarded per year by NIH alone. These are excellent sources of funding aimed at promoting R&D activities of US-based small businesses as well as collaborations with Academics.

SBIR/STTRs differ from traditional NIH mechanisms in that they are highly product driven and ultimately are seeking commercialization of novel therapies, diagnostics, devices, etc.

In this webinar we discuss process for applying, guidelines, key success components and insight into increasing chances for award.

View the SBIR/STTR webinar slide deck

To discuss the relevance of the SBIR/STTR programs to your R&D and to learn about non-dilutive funding that may be available to your organization, send us a note and we’ll get in touch with you directly!

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) supports research on many of the most common, costly, and chronic conditions to improve health.

With a FY2016 budget of over $1.8 Billion, the NIDDK supports R&D from basic research and early discovery stage projects all the way through late stage clinical trials. The NIDDK funds research in a wide variety of topics including Diabetes, Weight Management, Digestive, Kidney, Liver, Urologic and Endocrine Diseases, Nutrition, and many more.

In this webinar we cover:
• The various programs and mechanisms
• The application process
• Guidelines and regulations
• Key success components
• Insight into increasing chances for award

View the NIDDK webinar slide deck

To discuss the relevance of the NIDDK to your R&D and to learn about non-dilutive funding that may be available to your organization, send us a note and we’ll get in touch with you directly!